Objectif Research and development of a new microcapsule contrast agent with unique properties for MRI of both, the blood pool and internal organs. This dual agent approach allows patients to receive quicker and more convenient diagnosis, earlier disease detection and significantly reduces health care spending. The current problem relates to multiple and cost-& time intensive diagnosis - intended to be reduced to a 'one step diagnosis' by this new technology. Within the Craft project (step 2) we expect to develop a contrast agent suitable for the initial stages of clinical testing. Expertise and know-how of the Imaging market is available within the SME consortium. A suitable company (RTD performer) with the required know-how of the microcapsule spray dry technology is already identified. Champ scientifique engineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging Programme(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Thème(s) 1.1.1.-3. - Key action The "Cell factory" Appel à propositions Data not available Régime de financement EAW - Exploratory awards Coordinateur GOLDHAM BIOGLAN PHARMA GMBH Contribution de l’UE Aucune donnée Adresse Am Wasserberg 11 86441 ZUSMARSHAUSEN Allemagne Voir sur la carte Coût total Aucune donnée Participants (1) Trier par ordre alphabétique Trier par contribution de l’UE Tout développer Tout réduire SANOCHEMIA PHARMAZEUTIKA AG Autriche Contribution de l’UE Aucune donnée Adresse Boltzmanng-11 1090 WIEN Voir sur la carte Coût total Aucune donnée